{
    "clinical_study": {
        "@rank": "158272", 
        "brief_summary": {
            "textblock": "To compare cidofovir with a commonly used treatment regimen, ganciclovir given by mouth\n      (oral) and through an eye device (intraocular) , in order to determine the safety and\n      effectiveness of cidofovir in preventing vision loss in patients who have AIDS complicated\n      by CMV (cytomegalovirus) retinitis.\n\n      Cidofovir needs to be compared to ganciclovir to determine the best way to treat CMV\n      retinitis."
        }, 
        "brief_title": "Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis", 
        "condition": [
            "Cytomegalovirus Retinitis", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Retinitis", 
                "Cytomegalovirus Retinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "While cidofovir is effective in suppressing retinitis and prolonging time to progression, no\n      studies have compared cidofovir to other therapies and its place in the treatment of CMV\n      retinitis remains unexplored. By combining the ganciclovir intraocular device (slows\n      retinitis progression) with oral ganciclovir (has the potential to treat both the ocular\n      disease and to suppress dissemination to the contralateral eye and the viscera), without the\n      use of a central venous catheter, this combination has become increasingly common. For these\n      reasons, a comparative trial of cidofovir to other therapies is appropriate.\n\n      After being stratified by the clinic and by stage of disease, patients are randomized to 1\n      of 2 treatment arms: intravenous (IV) cidofovir (Group I) or intraocular ganciclovir device\n      plus oral ganciclovir (Group II). Group I: Cidofovir is administered IV once weekly for 2\n      consecutive weeks, then every 2 weeks thereafter. If progression occurs, oral ganciclovir is\n      added to treatment or if this regimen is not tolerated, patients are treated according to\n      the best medical judgment. Concurrent oral probenecid and intravenous hydration are\n      administered with each cidofovir infusion. Group II: An intraocular ganciclovir device is\n      surgically implanted at baseline and then every 6 to 8 months and ganciclovir is\n      administered orally. If more than 1 progression or unacceptable toxicity occurs, patients\n      are treated according to the best medical judgment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        You may be eligible for this study if you:\n\n          -  Are 13 years of age or older (parent or guardian consent required if under 18).\n\n          -  Agree to practice sexual abstinence or use effective birth control during and for 90\n             days after the study.\n\n          -  Have AIDS.\n\n          -  Have CMV retinitis.\n\n        Exclusion Criteria\n\n        You will not be eligible for this study if you:\n\n          -  Have a history of heart or kidney disease.\n\n          -  Have medical problems which would prevent you from completing the study.\n\n          -  Are pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "300", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000894", 
            "org_study_id": "ACTG 350"
        }, 
        "intervention": [
            {
                "intervention_name": "Cidofovir", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Probenecid", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Ganciclovir", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ganciclovir", 
                "Cidofovir", 
                "Probenecid"
            ]
        }, 
        "keyword": [
            "Infusions, Intravenous", 
            "Ganciclovir", 
            "Drug Therapy, Combination", 
            "Administration, Oral", 
            "Antiviral Agents", 
            "Drug Implants", 
            "Cytomegalovirus Retinitis", 
            "Eye", 
            "cidofovir"
        ], 
        "lastchanged_date": "February 22, 2011", 
        "link": [
            {
                "description": "Click here for more information about Ganciclovir", 
                "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=18"
            }, 
            {
                "description": "Haga clic aqu\u00ed para ver informaci\u00f3n sobre este ensayo cl\u00ednico en espa\u00f1ol.", 
                "url": "http://aidsinfo.nih.gov/clinicaltrials/htmltrials_sp.asp?an=0893"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA CARE Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "900331079"
                    }, 
                    "name": "Univ of Southern California / LA County USC Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Univ of Miami / Bascom Palmer Eye Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Emory Eye Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Univ / SOCA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Charity Hosp / Tulane Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Cornell Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "New York Hosp / Cornell Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "275997215"
                    }, 
                    "name": "Univ of North Carolina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Columbia", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29169"
                    }, 
                    "name": "Julio Arroyo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "775550435"
                    }, 
                    "name": "Univ of Texas Galveston"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2000", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000894"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2003"
    }, 
    "geocoordinates": {
        "Charity Hosp / Tulane Univ Med School": "29.951 -90.072", 
        "Cornell Univ Med Ctr": "40.714 -74.006", 
        "Emory Eye Clinic": "33.749 -84.388", 
        "Johns Hopkins Hosp": "39.29 -76.612", 
        "Julio Arroyo": "33.993 -81.074", 
        "New York Hosp / Cornell Med Ctr": "40.714 -74.006", 
        "Northwestern Univ / SOCA": "41.878 -87.63", 
        "UCLA CARE Ctr": "34.052 -118.244", 
        "Univ of Miami / Bascom Palmer Eye Institute": "25.789 -80.226", 
        "Univ of North Carolina": "35.913 -79.056", 
        "Univ of Southern California / LA County USC Med Ctr": "34.052 -118.244", 
        "Univ of Texas Galveston": "29.301 -94.798"
    }
}